Condensed Consolidated Statements of Stockholders’ (Deficit) Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common stock	Common stock Common A units	Common stock Common B units	Additional paid in capital	Accumulated deficit	Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Jan. 01, 2022		0	141,545	0
Beginning balance at Jan. 01, 2022	$ 185,432	$ 0	$ 223,379	$ 1,297	$ 0	$ (53,708)	$ 14,464
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	1,081				1,081
Corporate conversion of common units to common stock (in shares)		141,545	(141,545)
Corporate conversion of common units to common stock	0		$ (223,379)	$ (1,297)	224,676
Stock issued under stock incentive plans, net (in shares)		45
Stock issued under stock compensation incentive plans, net	(292)				(292)
Comprehensive income (loss)	87,107					58,286	28,821
Ending balance (in shares) at Oct. 01, 2022		141,590	0	0
Ending balance at Oct. 01, 2022	273,328	$ 0	$ 0	$ 0	225,465	4,578	43,285
Beginning balance (in shares) at Jul. 02, 2022		141,545
Beginning balance at Jul. 02, 2022	242,360	$ 0			224,666	(10,919)	28,613
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	799				799
Stock issued under stock incentive plans, net (in shares)		45
Comprehensive income (loss)	30,169					15,497	14,672
Ending balance (in shares) at Oct. 01, 2022		141,590	0	0
Ending balance at Oct. 01, 2022	$ 273,328	$ 0	$ 0	$ 0	225,465	4,578	43,285
Beginning balance (in shares) at Dec. 31, 2022	141,590	141,590	0	0
Beginning balance at Dec. 31, 2022	$ 227,335	$ 0	$ 0	$ 0	226,327	(38,443)	39,451
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	50,970				50,970
Proceeds from initial public offering, net of underwriting fees and offering costs of $42.5 million (in shares)		18,750
Proceeds from initial public offering, net of underwriting fees and offering costs of $42,473	295,027				295,027
Stock issued under stock incentive plans, net (in shares)		158
Stock issued under stock compensation incentive plans, net	(150)				(150)
Repurchase of common stock (in shares)		(45)
Repurchase of common stock	(699)				(699)
Dividends declared	(262,213)					(262,213)
Comprehensive income (loss)	$ 2,872					9,243	(6,371)
Ending balance (in shares) at Sep. 30, 2023	160,453	160,453	0	0
Ending balance at Sep. 30, 2023	$ 313,142	$ 0	$ 0	$ 0	571,475	(291,413)	33,080
Beginning balance (in shares) at Jul. 01, 2023		141,703
Beginning balance at Jul. 01, 2023	(12,571)	$ 0			227,335	(275,801)	35,895
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	49,113				49,113
Proceeds from initial public offering, net of underwriting fees and offering costs of $42.5 million (in shares)		18,750
Proceeds from initial public offering, net of underwriting fees and offering costs of $42,473	295,027				295,027
Comprehensive income (loss)	$ (18,427)					(15,612)	(2,815)
Ending balance (in shares) at Sep. 30, 2023	160,453	160,453	0	0
Ending balance at Sep. 30, 2023	$ 313,142	$ 0	$ 0	$ 0	$ 571,475	$ (291,413)	$ 33,080